Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 575-580

  Zoppini, Giacomo ^a   Targher, Giovanni ^a   Chonchol, Michel ^b   Negri, Carlo ^a   Stoico, Vincenzo ^a   Pichiri, Isabella ^a   Lippi, Giuseppe ^a   Muggeo, Michele ^a   Bonora, Enzo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Anaemia; Chronic kidney disease; Epidemiology; Mortality; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; ANEMIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBINS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS;

EID: 77953231879     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.12.008     Document Type: Article

References (26)

1. Al-Ahmad A., Rand W.M., Manjunath G., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001, 38:955-962.
2. Jurkovitz C.T., Abramson J.L., Vaccarino L.V., Weintraub W.S., McClellan W.M. Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol 2003, 14:2919-2925.
3. Anand I., McMurray J.J., Whitmore J., et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004, 110:149-154.
4. Chonchol M., Nielson C. Hemoglobin levels and coronary artery disease. Am Heart J 2008, 155:494-498.
5. KDOQI KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007, 50:471-530.
6. Vlagopoulos P.T., Tighiouart H., Weiner D.E., et al. Anemia is a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol 2005, 16:3403-3410.
7. Tong P.C., Kong A.P., So W.Y., et al. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in Chinese patients with type 2 diabetes. Diabetes Care 2006, 29:2439-2444.
8. Muggeo M., Verlato G., Bonora E., et al. The Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 1995, 38:318-325.
9. de Marco R., Locatelli F., Zoppini G., Verlato G., Bonora E., Muggeo M. Cause-specific mortality in type 2 diabetes. Diabetes Care 1999, 22:756-761.
10. Targher G, Zoppini G, Chonchol M, et al. Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals. Nutr Metab Cardiovasc Dis 2009; doi:10.1016/j.numecd.2009.10.002.
11. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483.
12. American Diabetes Association Standards of medical care in diabetes - 2009. Diabetes Care 2009, 32(Suppl. 1):S13-S61.
13. Robles N.R., Angulo E., Grois J., Barquero A. Comparative effects of fosinopril and irbesartan on hematopoiesis in essential hypertensives. Ren Fail 2004, 26:399-404.
14. Ting R.Z., Szeto C.C., Chan M.H., Ma K.K., Chow K.M. Risk factors of vitamin B12 deficiency in patients receiving metformin. Arch Intern Med 2006, 166:1975-1979.
15. Macdougall I.C. ACE-inhibitors and erythropoietin responsiveness. Am J Kidney Dis 2001, 38:649-651.
16. Joss N., Patel R., Paterson K., Simpson K., Perry C., Stirling C. Anaemia is common and predicts mortality in diabetic nephropathy. QJM 2007, 100:641-647.
17. Go A.S., Yang J., Ackerson L.M., et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the anemia in chronic heart failure: outcomes and resource utilization (ANCHOR) study. Circulation 2006, 113:2713-2723.
18. Sarnak M.J., Tighiouart H., Manjunath G., et al. Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol 2002, 40:27-33.
19. Grune T., Sommerburg O., Siems W.G. Oxidative stress in anemia. Clin Nephrol 2000, 53(Suppl. 1):S18-S22.
20. Eustace J.A., Astor B., Muntner P.M., Ikizler T.A., Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 2004, 65:1031-1040.
21. Chonchol M., Lippi G., Montagnana M., Muggeo M., Targher G. Association of inflammation with anaemia in patients with chronic kidney disease not requiring chronic dialysis. Nephrol Dial Transplant 2008, 23:2879-2883.
22. Mehdi U., Toto R.D. Anemia, diabetes, and chronic kidney disease. Diabetes Care 2009, 32:1320-1326.
23. Drueke T., Locatelli F., Clyne N., et al. CREATE investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006, 355:2071-2084.
24. Singh A., Saczech L., Tang K.L., et al. CHOIR investigators. Correction of anemia with epoietin-alfa in chronic kidney disease. N Engl J Med 2006, 355:2085-2098.
25. Phrommintikul A., Haas S.J., Elsik M., Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 2007, 369:381-388.
26. Pfeffer M.A., Burdmann E.A., Chen C.Y., et al. TREAT investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009, 361:2019-2032.